Objectives-In this study, we investigated the vascular characteristics of liver tumors on 3-dimensional (3D) and 2-dimensional (2D) contrast-enhanced ultrasonography (CEUS). The clinical value of these CEUS methods in the diagnosis of benign and malignant liver tumors was evaluated and compared.
T wo-dimensional (2D) contrast-enhanced ultrasonography (CEUS) has been widely used in the diagnosis and differential diagnosis of liver tumors. 1 However, lesion detection is often challenging [2] [3] [4] [5] because 2D CEUS only displays the 2D layout of tumor blood vessels and not their complex spatial relationships. 6 Static 3-dimensional (3D) CEUS is a clinically valuable tool in that it shows the blood supply of liver tumors. 7 Its only drawback is that the images are not acquired in real time. Recently developed dynamic 3D CEUS provides more accurate clinical information when used to evaluate the feeding blood vessels, internal structure, and boundaries of tumors, including those of the liver. 8, 9 However, the utility of 3D CEUS and postprocessing intelligent tomographic technology in the differential diagnosis of benign versus malignant liver tumors has yet to be evaluated. In this study, we compared the vascular characteristics of liver tumors using dynamic 3D CEUS and 2D CEUS and the diagnostic accuracy of the methods in distinguishing benign from malignant liver tumors.
Materials and Methods

Patients
This study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University, and written informed consent was obtained from each patient. From September 2012 to November 2014, 126 consecutive patients who were referred to our hospital for liver tumor characterization underwent conventional ultrasonography (US), 2D CEUS, and 3D CEUS examinations. In all of the patients, only the most conspicuous lesion was observed, whether the patient had a single tumor or multiple tumors; thus 126 tumors were included in the study. Patients' diagnoses were made on the basis of the results of a histopathologic analysis of a specimen obtained by percutaneous biopsy or during surgery; patients with diagnoses of benign tumors were also evaluated by contrast-enhanced computed tomography (CT) or contrast-enhanced magnetic resonance imaging (MRI) within 3 months of the diagnosis.
Two-Dimensional CEUS
Ultrasonography was performed with an iU22 unit (Philips Healthcare, Bothell, WA) equipped a 1-5-MHz convex array transducer (C5-1 curved array) at a mechanical index of 0.07 to 0.09. Color Doppler flow imaging was performed first. The US contrast agent sulfur hexafluoride (SonoVue; Bracco SpA, Milan, Italy), was injected via an elbow vein intravenously as a 1.4-to 1.8-mL bolus, followed by a 10-mL normal sterile saline flush. Digital cine loops were registered during both baseline and postcontrast US in the arterial, portal, and late phases (5-40, 50-85, and 120-250 seconds from the beginning of the injection, respectively).
Three-Dimensional CEUS At least 10 minutes after 2D CEUS, after clearance of the previously injected contrast agent, 3D CEUS was performed by the same sonographer who performed the conventional US and 2D CEUS examinations using the same iU22 unit but equipped with a 1-6-MHz transducer (X6-1 xMatrix array) at a mechanical index of 0.09 and a focusing ability or 2 to 25 cm in depth. Harmonic imaging was used, and the image was optimized for size, tissue contrast, and resolution. Depending on the size and depth of each lesion, an appropriate sweep angle (range, 458-608) was selected to encompass the entire lesion. SonoVue was then injected via an elbow vein intravenously as a 1.5-to 2.0-mL bolus, followed by a 10-mL normal sterile saline flush. The 3D sweep was started during a patient breath hold, and 3 volumetric data sets were acquired in the arterial, portal, and late phases (10-30, 40-60, and 120-140 seconds from the beginning of the injection, respectively). Each examination lasted approximately 5 minutes after the bolus injection.
Image Analysis
Reconstructed dynamic 3D CEUS images were analyzed by 2 sonographers who were not involved in the scanning and who were blinded to the diagnosis, clinical histories, and other imaging findings of the patients. The most conspicuous lesion in each patient was analyzed. Three-dimensional volumes were reviewed with commercially available proprietary software (QLAB; Philips Healthcare) approved for clinical use and capable of a volume-rendering mode and an intelligent tomographic technology (iSlice) mode. The iSlice software is used to display the data set in multiple contiguous parallel 2D slices, similar to CT and MRI, in 3 orthogonal planes: plane A, translatable from front to back; plane B, translatable from right to left; and plane C, translatable from top to bottom. To better display the region of interest, the sonographers were allowed to freely rotate and zoom the volume and to set several parameters, including the number of slices (range, 4-30), the interval slice (distance between the individual slices; range, 0.1-176 mm), and the depth (position of the slices in the volume; range, 0.6-150 mm). The clarity of the 3D images could be improved by manually adjusting factors such as the threshold, brightness, opacity, pseudocolor, and shear. The intralesional vascular perfusion characteristics of the tumors in the arterial phase were evaluated with the QLAB software.
All 2D and 3D images in the 3 phases of 2D and 3D CEUS were reviewed. The extent of tumor enhancement was categorized as hyperenhancement, isoenhancement, and hypoenhancement relative to adjacent normal liver parenchyma. The enhancement pattern of the tumors was categorized as center to periphery, a peripheral hypoechoic rim, and periphery to center relative to adjacent normal liver parenchyma.
The imaging performance of dynamic 3D CEUS was compared with that of 2D CEUS, including the contrast agent perfusion characteristics of the lesions in the arterial phase and the enhancement level in each phase, together with features of the feeding arteries, including their number and spatial relationships, origin, and continuity. The criteria used for CEUS in determining the benign or malignant nature of a lesion were in accord with the updated 2008 guidelines and good clinical practice recommendations for CEUS set by the European Federation of Societies for Ultrasound in Medicine and Biology.
The enhancement pattern and vascular features of a tumor can be seen on 2D CEUS, whereas the tumor perfusion process, including the characteristics of the feeder vessels and their spatial relationships within the tumor, can be followed dynamically by using dynamic 3D CEUS. To evaluate the tumor vasculature, the blood vessels were divided into 2 groups based on their origin, continuity, and complete or incomplete appearance as determined from the images obtained by the CEUS methods. In the "good" group, all of the feeder vessels and their origin could be seen, and their continuity was clear ( Figure 1 , A and B). In the "bad" group, neither the number nor the origin of the feeder vessels could be determined because they were discontinuous, incompletely shown, or not visible at all ( Figure 1 , C and D).
Statistical Analysis
The statistical analysis was performed by a biostatistician who was involved in the study design. The data were 
Results
The 126 patients included 61 men and 65 women with mean age of 43 6 16 years (range, 18-67 years). The tumors were classified as benign (40 hemangiomas, 6 hepatic adenomas, and 7 benign regenerative nodules with Budd-Chiari syndrome) or malignant (68 hepatocellular carcinomas and 5 intrahepatic cholangiocarcinomas). None of the 53 patients with benign tumors had hepatitis, whereas among the 73 patients with malignant tumors, hepatitis was diagnosed in 5 patients with intrahepatic cholangiocarcinomas. Among the 68 patients with hepatocellular carcinoma, 7 had Budd-Chiari syndrome, and the remaining 61 had hepatitis B virus infections. The mean diameters of the tumors as measured on US were 4.2 6 1.9 cm (range, 1.4-8.3 cm) in the benign group and 3.9 6 2.6 cm (range, 1.3-8.5 cm) in the malignant group. Patient characteristics are listed in Table 1 .
With the use of the contrast enhancement pattern and extent of the vasculature to distinguish between benign and malignant tumors and compared with the pathologic results, which were used as the reference standard, the sensitivity and specificity of 2D CEUS were 88.5% and 90.5%, respectively; for 3D CEUS, they were 90.0%, and 91.9%. Dynamic 3D CEUS and 2D CEUS were not significantly different (P > .05) in differentiating benign versus malignant liver tumors based on the enhancement patterns and the extent of the tumors (Table 2 ). However, in displaying the features of the feeder vessels, including their number, spatial relationships, origin, and continuity in the arterial phase, dynamic 3D CEUS was superior to 2D CEUS (P < .05), as shown in Table 3 . The number of feeder vessels seen in the arterial phase was significantly higher on dynamic 3D CEUS than 2D CEUS (Table 4) .
Dynamic 3D CEUS of the morphologic characteristics of the vasculature in the benign tumors showed relatively flat and regular vessels. Those in the tumor interior were also regular (Figures 2-4 ). In the malignant tumors, dynamic 3D CEUS showed twisted feeder Neither the number nor the origin of the feeder vessels could be determined because they were discontinuous, incompletely shown, or not visible at all. Table 5 ).
Discussion
According to Luo et al, 7 because most hepatic lesions receive their blood mainly from the hepatic arteries, detection of their characteristic vascularity is best achieved in the early phase of contrast-enhanced US.
Wang et al 8 also reported that feeder arteries were best displayed in the arterial phase of 3D CEUS. Therefore, in this study, the characteristics of feeder vessels and their relationship with the tumor as seen on 2D and 3D CEUS were evaluated only in the arterial phase.
Angiogenesis is the basis and prerequisite for tumor growth and metastasis. 10 Invasive capillaries are present inside and around most malignant tumors, whereas there is little evidence of angiogenesis associated with benign tumors. 11 Therefore, an evaluation of the blood supply of a suspicious lesion plays an important role in the differential diagnosis and treatment monitoring in patients with liver cancer. 12 Contrast-enhanced US objectively shows the tissue microcirculation and is thus widely used in the diagnosis and differential diagnosis of liver tumors. 13 Its diagnostic sensitivity and accuracy based on the degree of enhancement are comparable to the results obtained with CT and MRI. 14, 15 A limitation of 2D CEUS in the evaluation of hepatic tumors is that only the surface of the lesion is visualized, such that little information is provided regarding tumor perfusion. This factor results in a distorted stereoscopic display of the internal blood supply of a liver tumor and the spatial relationship between the tumor and its vessels, which increases the likelihood of a misdiagnosis.
Static 3D CEUS is based on angiographic 3D reconstruction techniques. It is used to show the blood supply of a tumor at a single moment, but it provides no information on its dynamic perfusion. Dynamic 3D CEUS relies on 3D image acquisition, reconstruction, and display of the area of interest under the conditions of US imaging and in a very short period. It generates a series of continuous 3D angiographic images automatically and instantly, thus providing a dynamic 3D perfusion image of the entire lesion volume, which shows the organization and structure of the tumor and its vasculature as well as the tumor perfusion process. 16 Dynamic observation of tumor arterial enhancement can aid in determining the nature of the tumor. 9 The iSlice reconstruction method provides realtime 3D CEUS volume information based on multiple parallel 2D CEUS image slices, similar to CT and MRI. By combining the information obtained with real-time 3D CEUS and the high resolution of 2D CEUS, this multilayered view of the tumor interior allows visualization of tumor perfusion and the relationship between adjacent feeder vessels and the tumor. This more accurate information aids in the diagnosis and response to therapy of liver tumors.
In our study, dynamic 3D CEUS was similar to 2D CEUS with respect to the extent of contrast enhancement in benign and malignant liver tumors during each phase. However, the display rate of liver tumor feeder vessels was significantly higher on dynamic 3D CEUS than 2D CEUS, as reported by Luo et al 7 using static 3D CEUS. We chose dynamic 3D CEUS, as it is currently the most advanced imaging technology and overcomes the limitations of static 3D CEUS. In the arterial phase, dynamic 3D CEUS was superior to 2D CEUS in revealing the vascular features of the tumor's feeder vessels (including their number, direction, and spatial relationships) and the blood perfusion characteristics of the tumor interior.
In this study, in the patient with Budd-Chiari syndrome and a liver tumor, 2D CEUS suggested its malignancy on the basis of rapid hyperenhancement of the tumor in the arterial phase ( Figure 4B) ; however, dynamic 3D CEUS and iSlice showed the spoked wheel pattern of the blood vessels, a characteristic of focal nodular hyperplasia (Figure 4, C and D) ; these benign regenerative nodules are often seen in Budd-Chiari syndrome. 17 Therefore, in this case, dynamic 3D CEUS and iSlice avoided misdiagnosis. In one of the patients with hemangioma, 2D CEUS showed a feeder vessel that was also suggestive of malignancy. However, dynamic 3D CEUS and iSlice showed that the blood vessel ( Figure  2B ) was the same one seen in the cross section on the tumor surface (Figure 2, C and D) and that it did not penetrate the lesion. Thus, 3D CEUS and iSlice can improve the 3D display of the blood supply of liver tumors; this anatomic information greatly improves diagnostic accuracy.
Although benign liver tumors also have feeder vessels, as seen on dynamic 3D CEUS, in the patients evaluated in this study, most of these blood vessels were relatively flat and regular, whereas internal blood vessels were thin, small, and rare (Figures 2 and 3) , unlike the winding, twisted, disorganized, and extensive internal network of blood vessels of malignant tumors (Figures 6  and 7) . Yukisawa et al 18 reported that the small channel between the central and peripheral blood vessels of liver metastatic carcinomas could be revealed by 3D CEUS, and the US findings correlated well with the pathologic findings. During tumor neovascularization, active tumor growth is accompanied by substantial changes in large vascular beds, as previously small and relatively homogeneous vessels rapidly proliferate to form multiple (arrowheads) . B, Two-dimensional CEUS shows a small feeder vessel (arrow) in the tumor (arrowheads), which is rapidly hyperenhanced in the arterial phase (17 seconds after SonoVue injection). C, Three-dimensional CEUS shows 2 relatively twisted feeder vessels (arrows). D, Three-dimensional iSlice reconstruction (slice thickness, 1.0 mm) shows more than 3 feeder vessels slice by slice (arrows). immature sinusoidal vessels with disordered branches, irregular lumen sizes, and rich anastomoses. These pathologic changes are readily revealed by CEUS. There was 1 volumetric data set acquired in each phase, and the time for each phase was 20 seconds in 3D CEUS. The 3D CEUS data were collected every second (frame rate, 2 Hz), and the 2D CEUS data were collected every second (frame rate, 12 Hz). The temporal resolution of 3D CEUS is less than that of 2D CEUS. This difference is also seen in other 3D US techniques such as 3D transesophageal echocardiography. Therefore, it is better to combine 2D with 3D CEUS to get more information and make an accurate diagnosis.
Our study had 3 main limitations. First, histopathologic confirmation was not possible in all patients with benign regenerative nodules. Second, the numbers of patients and, therefore, disease types were relatively small. Third, because we evaluated perfusion of the lesions only in the arterial phase, we may not have detected the full complement of feeder vessels. However, if the perfusion of a given area of the tumor in the arterial phase was not obvious, there was also no contrast between the tumor and the surrounding normal parenchyma in the portal and late phases, when both the tumor and normal liver were filled with contrast agent bubbles. The poor stereo effect of dynamic 3D CEUS in these later phases prevented the detection of additional feeder vessels.
In conclusion, in an evaluation of the anatomic structures of benign and malignant tumors in the arterial phase, dynamic 3D CEUS was superior to 2D CEUS, as the former showed the morphologic features of the tumor vasculature (including the number, direction, and spatial relationships of the tumor blood vessels) and the blood perfusion characteristics within and around the tumor. This detailed information acquired by real time 3D CEUS in combination with the high-resolution postprocessing tool iSlice contributes substantially to improving the diagnosis, therapeutic monitoring, and follow-up of patients with liver cancer. Threedimensional CEUS is an important complement to conventional 2D CEUS.
